Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6672993rdf:typepubmed:Citationlld:pubmed
pubmed-article:6672993lifeskim:mentionsumls-concept:C0020473lld:lifeskim
pubmed-article:6672993lifeskim:mentionsumls-concept:C0311400lld:lifeskim
pubmed-article:6672993lifeskim:mentionsumls-concept:C0011847lld:lifeskim
pubmed-article:6672993lifeskim:mentionsumls-concept:C1707520lld:lifeskim
pubmed-article:6672993lifeskim:mentionsumls-concept:C0549193lld:lifeskim
pubmed-article:6672993pubmed:dateCreated1984-5-18lld:pubmed
pubmed-article:6672993pubmed:abstractTextBlood viscosity, plasma viscosity and erythrocyte filterability were studied in 46 diabetic and in 24 hyperlipidemic patients and were compared with those of a group of normal controls; 35 diabetics were type I (IDDM, 13 of whom complication-free and 22 with micro- and macroangiopathy), 11 diabetics were type II (NIDDM, 5 of whom complication-free and 6 with micro- and macroangiopathy). Erythrocyte filterability was lower in type I and II diabetes than in controls, and was also lower in diabetics with vascular complications than in complication-free patients. Erythrocyte filterability inversely correlated with HbA1c and with plasma uric acid levels. The hyperlipidemic group included 6 type IIa, 6 type IIb, 8 type IV and 4 type V patients. All hyperlipidemic patients were examined before and during diet and drug therapy. In all the hyperlipidemic patients blood viscosity inversely correlated with HDL-cholesterol, while plasma viscosity directly correlated with plasma uric acid. All these findings suggest that some hemorheological factors can play a role in the onset and progression of vascular complications of diabetes mellitus and hyperlipidemias, and that the hemorheological changes correlate with the severity of the metabolic abnormalities.lld:pubmed
pubmed-article:6672993pubmed:languageitalld:pubmed
pubmed-article:6672993pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6672993pubmed:citationSubsetIMlld:pubmed
pubmed-article:6672993pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6672993pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6672993pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6672993pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6672993pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6672993pubmed:statusMEDLINElld:pubmed
pubmed-article:6672993pubmed:issn0390-5748lld:pubmed
pubmed-article:6672993pubmed:authorpubmed-author:MuggeoMMlld:pubmed
pubmed-article:6672993pubmed:authorpubmed-author:CrepaldiGGlld:pubmed
pubmed-article:6672993pubmed:authorpubmed-author:PadovanDDlld:pubmed
pubmed-article:6672993pubmed:authorpubmed-author:CalabròAAlld:pubmed
pubmed-article:6672993pubmed:authorpubmed-author:MoghettiPPlld:pubmed
pubmed-article:6672993pubmed:authorpubmed-author:BusinaroVVlld:pubmed
pubmed-article:6672993pubmed:issnTypePrintlld:pubmed
pubmed-article:6672993pubmed:volume13 Suppl 3lld:pubmed
pubmed-article:6672993pubmed:ownerNLMlld:pubmed
pubmed-article:6672993pubmed:authorsCompleteYlld:pubmed
pubmed-article:6672993pubmed:pagination165-79lld:pubmed
pubmed-article:6672993pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6672993pubmed:meshHeadingpubmed-meshheading:6672993-...lld:pubmed
pubmed-article:6672993pubmed:meshHeadingpubmed-meshheading:6672993-...lld:pubmed
pubmed-article:6672993pubmed:meshHeadingpubmed-meshheading:6672993-...lld:pubmed
pubmed-article:6672993pubmed:meshHeadingpubmed-meshheading:6672993-...lld:pubmed
pubmed-article:6672993pubmed:meshHeadingpubmed-meshheading:6672993-...lld:pubmed
pubmed-article:6672993pubmed:meshHeadingpubmed-meshheading:6672993-...lld:pubmed
pubmed-article:6672993pubmed:meshHeadingpubmed-meshheading:6672993-...lld:pubmed
pubmed-article:6672993pubmed:meshHeadingpubmed-meshheading:6672993-...lld:pubmed
pubmed-article:6672993pubmed:meshHeadingpubmed-meshheading:6672993-...lld:pubmed
pubmed-article:6672993pubmed:meshHeadingpubmed-meshheading:6672993-...lld:pubmed
pubmed-article:6672993pubmed:meshHeadingpubmed-meshheading:6672993-...lld:pubmed
pubmed-article:6672993pubmed:meshHeadingpubmed-meshheading:6672993-...lld:pubmed
pubmed-article:6672993pubmed:meshHeadingpubmed-meshheading:6672993-...lld:pubmed
pubmed-article:6672993pubmed:year1983lld:pubmed
pubmed-article:6672993pubmed:articleTitle[Correlation of metabolic and hemorrheological parameters in diabetes and hyperlipidemia].lld:pubmed
pubmed-article:6672993pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6672993pubmed:publicationTypeEnglish Abstractlld:pubmed
pubmed-article:6672993pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed